TRU-SENTIMENT ยท DeltaNeutral
BIIB Trading Analysis - 09/10/2026 04:33 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
BIIB (Biogen Inc. Common Stock) at $215.43. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $1,908,780 vs put $12,210. RSI 51.4.
- Symbol
- BIIB
- Price
- $215.43
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-10 16:33:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $1,908,780
- Put dollar volume: $12,210
The options flow sentiment is strongly bullish, indicating a positive outlook for the stock.
Key Statistics: BIIB
Fundamental Snapshot
Valuation
| P/E (Trailing) | 37.43 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 4.97 |
Profitability
| EPS (Trailing) | $5.63 |
| EPS (Forward) | N/A |
| ROE | 4.43% |
| Net Margin | 8.32% |
Financial Health
| Revenue (TTM) | $10.03B |
| Debt/Equity | 0.39 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
๐ Analysis
News Headlines & Context:
Recent news headlines for BIIB include:
- Insider Buying: BIIB's executive vice president, Jeffrey H. Coplan, purchased 5,000 shares on September 8, 2026.
- BIIB's competitor, Cigna Group (CI), reported better-than-expected Q2 earnings on August 5, 2026.
- Bluebird Bio (BIRD) announced positive results from its Phase 3 trial for a sickle cell disease treatment on September 1, 2026.
These headlines suggest that there is increased insider buying activity and positive developments in the biotech sector, which could have a positive impact on BIIB's stock price.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $10,027,900,000
- Trailing EPS: $5.63
- Trailing P/E: 37.43
- Price-to-Book: 4.97
- Debt-to-Equity: 0.39
- Return on Equity (ROE): 4.43%
- Gross Margin: 73.99%
- Operating Margin: 10.09%
- Profit Margin: 8.32%
BIIB's fundamentals indicate a relatively high P/E ratio and a healthy profit margin. However, the debt-to-equity ratio and ROE may be areas of concern.
Current Market Position:
Current price: $215.43
Recent price action: The stock has been trading in a range with a recent uptrend.
Key support and resistance levels:
- Support: $210.54 (from daily history)
- Resistance: $222.15 (from daily history)
Technical Analysis:
Technical Indicators
SMA trends:
- 5-day SMA: $216.80
- 20-day SMA: $216.71
- 50-day SMA: $209.33
The stock is currently trading above its 50-day SMA, indicating a bullish trend.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $1,908,780
- Put dollar volume: $12,210
The options flow sentiment is strongly bullish, indicating a positive outlook for the stock.
Key Price Levels:
25-Day Price Forecast:
BIIB is projected for $217.11 to $224.92
Based on current technical trends, momentum, and indicators, the stock is expected to continue its uptrend.
Defined Risk Strategy Recommendations:
Based on the price forecast, here are three recommended defined risk strategies:
- Bull Call Spread: Buy 1 BIIB 261016C00210000 (strike $210.0) and sell 1 BIIB 261016C00220000 (strike $220.0) @ $1.35 debit
- Iron Condor: Sell 1 BIIB 261016P00200000 (strike $200.0) and buy 1 BIIB 261016P00210000 (strike $210.0), sell 1 BIIB 261016C00220000 (strike $220.0) and buy 1 BIIB 261016C00230000 (strike $230.0) @ $2.56 credit
- Protective Put: Buy 1 BIIB 261016P00210000 (strike $210.0) @ $5.30 debit
These strategies align with the projected price range and offer a defined risk approach.
View BIIB Options Chain
Risk Factors:
- Technical warning signs: RSI and MACD indicate a potential pullback.
- Sentiment divergences: None observed.
- Volatility and ATR considerations: Recent volatility may increase.
These risk factors should be considered when evaluating the trade.
Overall Bias & Conviction Level:
Overall bias: Bullish
Conviction level: High
One-line trade idea: Buy BIIB with a bullish bias and defined risk strategies.